Triamcinolone Hexacetonide Injection shortage
Triamcinolone Hexacetonide Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 25, 2026.
Triamcinolone hexacetonide injection is currently in shortage, though the 40 mg/2 mL strength still has at least one maker reporting supply. No other manufacturers are tracked for this medicine, so availability may be limited.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Triamcinolone Hexacetonide Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 15, 2026Currently in shortage1 of 1 product affected.
-
May 4, 2021First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Medexus 📞 1-855-336-3322 Option 9 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Triamcinolone Hexacetonide Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Triamcinolone Hexacetonide Injection? options further down this page.
Why is Triamcinolone Hexacetonide Injection in shortage?
Since this shortage is listed as current, you might expect to hear about a supply problem — but honestly, the FDA data for this particular product doesn't include a specific reason for why it's on the shortage list. The manufacturer, Medexus, did not share a public explanation for why it was added.
What I can tell you from the data is that the Medexus product — Hexatrione, triamcinolone hexacetonide injection, 40 mg/2 mL — is currently listed as available. So at least from this manufacturer, that specific strength and package size is showing as accessible right now.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Triamcinolone Hexacetonide Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Triamcinolone Hexacetonide Injection?
Triamcinolone hexacetonide injection is currently on the FDA drug-shortage list. I know that can feel unsettling, so let me walk you through what the data actually shows.
The single strength on this record, 40 mg/2 mL, currently has an available source. No strength of this medicine is listed as unavailable right now. So the version you take is being reported as in supply.
This shortage has been in place for over a year, and one manufacturer, Medexus, is on the record and reporting its product (brand name Hexatrione, 40 mg/2 mL) as available. The overall supply risk is listed as medium. No estimated-recovery date is provided, but the fact that the strength still has a source is a reassuring sign.
Here is what you can do:
- Do not stop, skip, or change your dose on your own.
- Because your strength still has supply, ask your pharmacy to order it — pharmacies can check wholesalers and other manufacturers.
- If your pharmacy cannot locate it, ask your prescriber or pharmacist about the best next step for you.
- The manufacturer's contact number is listed on this page for reference; pharmacies usually handle those calls.
This is national, manufacturer-reported information and may not match your local pharmacy's stock or your personal situation.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Therapeutic equivalents & pricing 1 productclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Hexatrione 2% 40 mg/2mL | Medexus | 1 ampule | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Triamcinolone Hexacetonide Injection — that fall in the same broad treatment class (glucocorticoids) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other rheumatology shortages
Triamcinolone Hexacetonide Injection shortage FAQs
Is Triamcinolone Hexacetonide Injection in shortage?
Which products are affected?
When will Triamcinolone Hexacetonide Injection be available again?
What should I do if I take Triamcinolone Hexacetonide Injection?
Still have a question about the Triamcinolone Hexacetonide Injection shortage?
Ask a pharmacist about this shortage →View Triamcinolone Hexacetonide Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.